BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 24833728)

  • 1. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents.
    Roness H; Kalich-Philosoph L; Meirow D
    Hum Reprod Update; 2014; 20(5):759-74. PubMed ID: 24833728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of chemotherapy-induced ovarian damage.
    Roness H; Kashi O; Meirow D
    Fertil Steril; 2016 Jan; 105(1):20-9. PubMed ID: 26677788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility after breast cancer treatment.
    Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian damage from chemotherapy and current approaches to its protection.
    Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
    Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present and future fertility preservation strategies for female cancer patients.
    Georgescu ES; Goldberg JM; du Plessis SS; Agarwal A
    Obstet Gynecol Surv; 2008 Nov; 63(11):725-32. PubMed ID: 18928577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
    Decanter C; Robin G
    Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility sparing in cancer patients.
    Bouchlariotou S; Tsikouras P; Benjamin R; Neulen J
    Minim Invasive Ther Allied Technol; 2012 Jul; 21(4):282-92. PubMed ID: 21919808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of fertility preservation procedures in a cohort of female patients with cancer.
    Jenninga E; Louwe LA; Peters AA; Nortier JW; Hilders CG
    Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):170-3. PubMed ID: 22137982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fertility preservation techniques in women of reproductive age ].
    Vulliemoz N ; Gaitzsch H ; Primi M-P ; Wunder D ; Perey L ; Streuli I
    Rev Med Suisse; 2014 Oct; 10(447):1961-2, 1964-6, 1968. PubMed ID: 25518205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for fertility preservation in young early breast cancer patients.
    Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
    Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy and fertility.
    Blumenfeld Z
    Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):379-90. PubMed ID: 22281514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of first-line cancer treatment on the follicle quality in cryopreserved ovarian samples from girls and young women.
    Pampanini V; Wagner M; Asadi-Azarbaijani B; Oskam IC; Sheikhi M; Sjödin MOD; Lindberg J; Hovatta O; Sahlin L; Björvang RD; Otala M; Damdimopoulou P; Jahnukainen K
    Hum Reprod; 2019 Sep; 34(9):1674-1685. PubMed ID: 31411325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female fertility loss and preservation: threats and opportunities.
    Salama M; Winkler K; Murach KF; Seeber B; Ziehr SC; Wildt L
    Ann Oncol; 2013 Mar; 24(3):598-608. PubMed ID: 23129121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric and Teen Ovarian Tissue Removed for Cryopreservation Contains Follicles Irrespective of Age, Disease Diagnosis, Treatment History, and Specimen Processing Methods.
    Duncan FE; Pavone ME; Gunn AH; Badawy S; Gracia C; Ginsberg JP; Lockart B; Gosiengfiao Y; Woodruff TK
    J Adolesc Young Adult Oncol; 2015 Dec; 4(4):174-83. PubMed ID: 26697267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility preservation and reproductive health in the pediatric, adolescent, and young adult female cancer patient.
    Trudgen K; Ayensu-Coker L
    Curr Opin Obstet Gynecol; 2014 Oct; 26(5):372-80. PubMed ID: 25160517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
    Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced damage to ovary: mechanisms and clinical impact.
    Bedoschi G; Navarro PA; Oktay K
    Future Oncol; 2016 Oct; 12(20):2333-44. PubMed ID: 27402553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New trends in female fertility preservation: in vitro maturation of oocytes.
    Berwanger AL; Finet A; El Hachem H; le Parco S; Hesters L; Grynberg M
    Future Oncol; 2012 Dec; 8(12):1567-73. PubMed ID: 23231518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.